发明名称 Methods of treating hepatic encephalopathy
摘要 The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
申请公布号 US8969398(B2) 申请公布日期 2015.03.03
申请号 US201313768617 申请日期 2013.02.15
申请人 Salix Pharmaceuticals, Ltd. 发明人 Forbes William
分类号 A61K31/437;A61K31/08;A61K31/352;A61K31/395;A61K31/4164;A61K31/426;A61K31/4439;A61K31/606;A61K31/7016;A61K31/785;A61K38/14;A61K38/31;A61K45/06 主分类号 A61K31/437
代理机构 McCarter & English LLP 代理人 McCarter & English LLP ;Sparks Jonathan M.;DeGrazia Michael J.
主权项 1. A method of decreasing a subject's risk of a hepatic encephalopathy (HE) breakthrough episode comprising administering rifaximin daily for a period of about 12 months or longer to a subject suffering from HE, thereby decreasing the subject's risk of an HE breakthrough episode, wherein a breakthrough episode is defined as an increase of the Conn score to Grade ≧2 or an increase in Conn score of 1 and asterixis grade of 1 for subjects having a baseline Conn score of 0.
地址 Raleigh NC US